Access to unfunded treatment for our Lills

At 34 weeks pregnant, Lilly and Guy’s world was flipped upside down when Lilly was diagnosed with stage 3 triple negative breast cancer (TNBC), a rare and aggressive form. In the final weeks of her pregnancy, she began chemotherapy, before welcoming her beautiful baby girl, Vienna, safely into the world.

Over the past two months, Lills has truly shown us what she’s made of. She’s faced everything with strength and grace. It’s been incredibly special watching her become a mum to little Vienna, who has already brought so much love to their lives. Lills has now resumed treatment which involves a further three months of chemotherapy before surgery and radiation.

TNBC does not respond to hormone therapy which is typically used in the months and years after initial treatment to help reduce the risk of recurrence. TNBC has one of the highest rates of recurrence among breast cancer. Keytruda (pembrolizumab) has been proven to meaningfully reduce the risk of TNBC returning amongst patients. While this drug is funded for Stage 4 TNBC patients, as Lilly is Stage 3 it is unfunded. To access this potentially lifesaving drug will cost $100,000.

Lilly and Guy have already been overwhelmed with the support received from friends near and far. Many others have asked how they can help, any contribution to help her access Keytruda, big or small, would be gratefully received.

Thank you for being part of Lilly’s journey and helping make this next step of treatment possible.